Integrated approach for optimal use of medication in long-term care centres in Quebec (OPUS-AP – PEPS)
Launched in 2017 in Quebec, the Optimizing Practices, Use, Care and Services - Antipsychotics (OPUS-AP) collaborative aims to reduce or discontinue the inappropriate use of antipsychotic medications in long-term care centres. Phase 3 will integrate the PEPS program (Projet d'évaluation de la personnalisation des soins infirmiers, médicaux et pharmaceutiques), leading to the rollout of the approach for the optimal use of medications in long-term care centres in all of the province’s CHSLDs, as well as in long-term care homes and alternative homes.
:quality(80))
- Topics
- Long-term care
- Aging in place
- Patient safety
- Audience
Healthcare leader
Policy advisor or analyst
Point of care provider
Based on the Appropriate Use of Antipsychotics (AUA) approach, the Optimizing Practices, Use, Care and Services – Antipsychotics (OPUS-AP) collaborative is a partnership between Healthcare Excellence Canada, the Ministry of Health and Social Services of Quebec, the Institut national d’excellence en santé et en services sociaux (INESSS), and Quebec’s leading experts from the four integrated university health and social services networks. OPUS-AP aims to improve the quality and experience of care for residents living with a major neurocognitive disorder, as well as for their families, care partners and providers.
The OPUS-AP collaborative has three phases:
Phase 1 (April 2017 to October 2018): 24 CHSLDs participated (one unit per CHSLD);
Phase 2 (January 2019 to April 2020): 129 CHSLDs participated (329 units);
Phase 3 (October 2022 to March 2026): all 313 publicly funded CHSLDs, long-term care homes and alternative homes participating.
“This is about putting our scientific knowledge into action. Through this collaborative, we have created a highway of knowledge transfer, and by working together, we will make change happen.”
Phase 1
In Phase 1 of the OPUS-AP collaborative, 85.9% of residents for whom deprescription was attempted had their antipsychotic medication dosage reduced or discontinued entirely. Among the participating CHSLDs, the collaborative also had a positive impact on patient experience, population health, and healthcare provider work-life balance.
You can read more about phase 1 results in the OPUS-AP Results Poster for Phase 1.
For more details about phase 1 of OPUS-AP, including a testimonial from one of our participating unit chiefs and project managers, you can watch the video.
Phase 2
Phase 2 took place between March 2019 and April 2020 in 329 units of 129 CHSLDs. It was successful in 77.1% of the 1,402 residents for whom deprescription was attempted (47.1% discontinued their use entirely and 30% reduced their dosage).
In Phase 2 of the OPUS-AP collaborative, the team supported an additional 129 CHSLDs in Quebec in rolling out the AUA approach. To learn about the train-the-trainer approach being implemented as part of this collaborative, you can watch the video.
Phase 2 Regions
Centre intégré de santé et de services sociaux de l’Abitibi-Témiscamingue
Centre intégré de santé et de services sociaux du Bas-Saint-Laurent
Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
Voir la carte
Centre intégré de santé et de services sociaux de Chaudière-Appalaches
Centre intégré de santé et de services sociaux de la Côte-Nord
CLSC Naskapi
Centre intégré universitaire de santé et de services sociaux de l’Estrie – Centre hospitalier universitaire de Sherbrooke
Centre intégré de santé et de services sociaux de la Gaspésie
Centre intégré de santé et de services sociaux des Îles
Centre intégré de santé et de services sociaux de Lanaudière
Centre intégré de santé et de services sociaux des Laurentides
Centre intégré de santé et de services sociaux de Laval
Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Centre intégré de santé et de services sociaux de la Montérégie-Centre
Centre intégré de santé et de services sociaux de la Montérégie-Est
Centre intégré de santé et de services sociaux de la Montérégie-Ouest
Centre intégré universitaire de santé et de services sociaux de l’Ouest-de-l’Île-de-Montréal
Centre intégré universitaire de santé et de services sociaux du Centre-Ouest-de-l’Île-de-Montréal
Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l’Île-de-Montréal
Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal
Centre intégré universitaire de santé et de services sociaux de l’Est-de-l’Île-de-Montréal
Centre universitaire de santé McGill (CUSM)
Centre intégré de santé et de services sociaux de l’Outaouais
Centre intégré universitaire de santé et de services sociaux du Saguenay–Lac-St-Jean
Phase 3
After a two-year pause due to the pandemic, Phase 3 was launched under the auspices of Quebec’s Ministry of Health and Social Services and integrated the PEPS program, an initiative of the CIUSSS de la Capitale-Nationale which also begun in 2017, and aimed at reducing the use of all types of medications for all CHSLD residents through the optimization of professionals’ roles. The integrated OPUS-AP – PEPS approach for optimal use of medication in long-term care centres will be rolled out in all publicly funded CHSLDs in the province, under the auspices of the Ministry of Health and Social Services and in partnership with the CIUSSS de l’Estrie - Centre hospitalier universitaire de Sherbrooke and Healthcare Excellence Canada. It is also part of Measure 9 of Quebec’s action plan for long-term care (Plan d’action pour l’hébergement de longue durée 2021-2026 - Pour le mieux-être des personnes hébergées).
:quality(80))
:quality(80))
:quality(80))